Home > Insider Trading > Filing (0001415889-25-002287)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1826667	Trisalus Life Sciences Inc.	TLSI	Surgical & Medical Instruments & Apparatus (3841)	853009869

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2050748	Emmett James Young	6272 W. 91St Ave. Westminster CO 80031	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-01-27	12,500	$0.00	21,726	No	4	A	Direct
Common Stock	Acquisiton	2025-01-27	24,000	$5.40	24,000	No	4	P	Indirect	By Kathleen A. Young Living Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Indirect	By Kathleen A. Young Living Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2025-01-27	75,000	$0.00	75,000	$5.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
75,000		2035-01-26	No	4	A	Direct

Footnotes

Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on January 1, 2025, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.
One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of January 1, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.